Overview:
The AIA, while fundamentally a U.S. law, has global implications. With innovations transcending borders and collaborations spanning continents, it’s crucial to comprehend the international reach of 35 USC 102 and how it integrates joint research activities. In Lesson 5.4, we elucidate the provisions of 102(c) and 102(d), focusing on foreign jurisdictions and joint research agreements and their impacts on patentability.
Full Detailed Analysis with MPEP Reference Citings:
- 102(c) – Joint Research AgreementsAs outlined in MPEP § 2155, 102(c) addresses the treatment of inventions derived from joint research agreements (JRAs). Specifically, this provision states:
- When determining patentability, disclosures made by a party of a JRA or by a party who obtained the disclosed subject matter directly or indirectly from a party of the JRA will not be treated as prior art under 102(a)(2), provided the claimed invention was made as a result of activities within the scope of the JRA.
- For the exemption to apply, the JRA must have been in effect on or before the effective filing date of the claimed invention.
This section accommodates the collaborative nature of innovation, recognizing that multiple entities might work together and share insights without intending to jeopardize each other’s patent rights.
- 102(d) – Foreign Application Priority and U.S. Patent EffectivityReferencing MPEP § 2136, 102(d) is vital for understanding the relationship between foreign patent applications and their U.S. counterparts. Specifically:
- If an inventor files for a patent in a foreign country and then files in the U.S., the U.S. filing can take the priority of the foreign filing date, provided it’s within a year. However, the U.S. filing’s “effective filing date” for determining prior art will be the U.S. filing date, not the foreign one.
- In simple terms, while the U.S. application might benefit from the foreign filing date in some respects, it won’t change what constitutes prior art for the U.S. application.
- AIA 102(d) says patents and published applications are effective as prior art as of its “effective filing date.”
- This simplifies it because you can go all the way back to the earliest filing in the chain, even if it’s a foreign patent application.
Bullet Points:
- 102(c) Joint Research Agreements:
- Disclosures by parties of a JRA or those derived from JRA parties are not treated as prior art under specific conditions.
- Collaborative innovations made under a valid JRA are protected from becoming inadvertent prior art.
- 102(d) Foreign Applications & U.S. Priority:
- U.S. applications can use the filing date of a prior foreign application for some benefits.
- The “effective filing date” for determining prior art remains the U.S. filing date, not the foreign one.
Key Summary:
With the global nature of innovation, the AIA’s provisions in 102(c) and 102(d) are instrumental in ensuring fair play, both in international patent applications and collaborative research ventures. While joint research agreements under 102(c) protect shared knowledge from inadvertently invalidating patent claims, 102(d) provides clarity on how foreign filing dates interact with U.S. patent applications. By grasping these nuances, inventors and patent practitioners can seamlessly integrate their international pursuits and collaborative endeavors into the U.S. patent landscape.